To The Moon

$Chewy, Inc.(CHWY)$ $Petco Health and Wellness Company, Inc.(WOOF)$  $Freshpet(FRPT)$  🚀🐾📊 Chewy $CHWY Reclaims Momentum: Earnings Quality Meets Technical Inflection 📊🐾🚀

$CHWY is trading firmly in the open session, extending earlier strength following its Q4 release. This is not simply a reactive bounce. The move reflects a shift in both earnings quality and positioning after an extended period of downside pressure.

After declining -31% YoY and printing a two-year low at $22.75, the stock entered this result with sentiment washed out and expectations compressed. That backdrop matters, because it lowers the bar for a meaningful re-rating when fundamentals begin to stabilise.

📊 Q4 Snapshot vs Expectations

EPS came in at $0.27 versus $0.28 expected, while revenue printed at $3.265B, marginally ahead of the $3.26B consensus. The slight EPS miss is largely irrelevant in this context. The market is correctly prioritising margin expansion and cash flow durability over a single-quarter earnings variance.

📈 Normalised Growth Tells the Real Story

At face value, revenue growth of +0.5% YoY appears uninspiring. Adjusting for the extra week in the prior year reframes this to approximately +8.1% normalised growth, pointing to a business that is stabilising rather than stagnating.

More importantly, profitability is scaling with discipline. Free cash flow reached a record $562.4M for the year, with Q4 alone delivering $232M, up +48.1% YoY. Adjusted EBITDA rose 26% to $719.2M. This is a clear transition toward a model driven by cash generation rather than top-line expansion alone.

🧠 Autoship: The Structural Advantage

Autoship now represents 84% of total revenue, up from 80.6% a year ago, contributing $2.74B in Q4 sales. This is the defining feature of the investment case.

What sits beneath that number is a highly predictable, recurring revenue stream that reduces customer acquisition volatility and enhances lifetime value. In practical terms, it embeds subscription-like economics into a retail framework, a characteristic that deserves a structural premium if sustained.

📊 Technical Inflection Is Now in Play

The chart structure reinforces the fundamental shift. The broader trend has been a controlled downtrend channel since late 2025, with repeated lower highs and consistent pressure along the upper bands.

That dynamic began to exhaust as price tagged the lower Bollinger Band near $22–23, a typical volatility extreme. The subsequent reversal has been decisive, with price reclaiming short-term EMAs (13 and 21) and now pressing into the 55 EMA, which acts as the key pivot between continuation and reversal.

At the same time, both Bollinger Bands and Keltner Channels are beginning to compress after a period of expansion. This volatility reset often precedes a more sustained directional move.

The near-term structure is clean. Resistance sits in the $27.00–27.50 zone, with a break opening a path toward $29–30. On the downside, support is building around $24.50–25.00, with a loss of $23.00 undermining the recovery thesis.

📊 Margins and Model Evolution

Margin expansion continues to validate management’s strategy. Gross margin improved to 29.4%, while EBITDA margin reached 5.0%, both showing clear year-on-year expansion.

These gains are being driven by a combination of advertising efficiency, mix shift into higher-margin categories such as healthcare, and ongoing supply chain optimisation. This is structural improvement, not temporary cost control.

🐂 Bull vs Bear Framing

The bull case rests on a high-quality revenue base, strong and accelerating free cash flow, and continued gains in wallet share, with NSPAC rising to $591.

The bear case is more macro in nature. Industry growth remains constrained to low-single digits, with flat pet household formation limiting organic expansion. Execution, not tailwinds, will determine the outcome from here.

There is also an accounting nuance worth noting. Adjusted net income declined -4.3% YoY due to lower share-based compensation add-backs. While this creates a negative optical headline, it reflects reduced dilution and is fundamentally constructive.

📊 Positioning and Flow

Options activity shows over $500K in single-leg calls, suggesting a shift toward bullish positioning. Given the prior drawdown, this likely reflects a mix of short covering and early-stage accumulation rather than late-cycle momentum chasing.

⚖️ Verdict

The bias is bullish, with confirmation dependent on technical follow-through.

Chewy is no longer a pure growth story. It is evolving into a cash flow-generative platform with embedded recurring revenue and expanding margins. That combination is rarely priced correctly in the early stages of transition.

If price can sustain above the EMA cluster and reclaim higher resistance levels, the current move has the potential to evolve from a reflex rally into a more durable trend reversal.

👉❓ If $CHWY successfully reclaims and holds above the $27–28 range, does that mark the point where institutional capital begins to reprice it as a recurring revenue platform rather than a traditional retailer?

📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀

Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀